Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis
aCenter for Drug Safety Evaluation and Research, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
bNanhu Brain-Computer Interface Institute, Hangzhou 311100, China
cThe Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
dKey Laboratory of Drug Safety Evaluation and Research of Zhejiang Province, Center of Safety Evaluation and Research, Hangzhou Medical College, Hangzhou 310059, China
eHangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou 310018, China
fSchool of Medicine, Hangzhou City University, Hangzhou 310015, China
gTaizhou Institute of Zhejiang University, Taizhou 318000, China
* Corresponding authors.
收起